Prostate cancer is not fully preventable, but you can meaningfully lower your risk through lifestyle choices. With roughly 334,000 new cases expected in the U.S. in 2026 alone, it remains the most common non-skin cancer in men. Some risk factors, like age, race, and inherited genetics, are completely outside your control. Others, like body weight, physical activity, and diet, are not.
Genetic Risk You Can’t Change
Inherited gene mutations account for a significant share of prostate cancer cases, and no lifestyle change can erase that risk. Men who carry a BRCA2 mutation have roughly a 27% chance of developing prostate cancer by age 75 and a 60% chance by age 85. That’s more than four times the rate seen in the general population. Mutations in a specific cluster region of the BRCA2 gene push the risk even higher, to an estimated 44% by age 75 and 78% by age 85.
BRCA1 mutations also raise risk, though less dramatically. Men under 65 with a BRCA1 mutation are about 3.5 times more likely to develop prostate cancer than men without one. Family history matters even without a known mutation. If your father or brother had prostate cancer, your own risk roughly doubles. Black men face the highest incidence rates of any racial group, for reasons that likely involve both genetics and disparities in healthcare access.
How Body Weight Affects Outcomes
Carrying excess weight doesn’t just raise your chances of getting prostate cancer. It makes the disease more dangerous when it does appear. Overweight and obese men at diagnosis are nearly twice as likely to die from locally advanced prostate cancer compared to men at a normal weight. Even modest excess weight matters: men with a BMI between 25 and 30 were more than 1.5 times more likely to die from their cancer than normal-weight men. After five years, prostate cancer mortality was under 7% for men with a normal BMI, compared to about 13% for men with a BMI of 25 or higher.
The link between obesity and aggressive prostate cancer likely involves hormones. Excess body fat raises estrogen levels, increases chronic inflammation, and alters insulin signaling, all of which can create a more hospitable environment for tumor growth. Losing weight won’t guarantee prevention, but maintaining a healthy weight is one of the most impactful things you can do.
What Exercise Does Inside Your Body
Regular physical activity appears to lower prostate cancer risk through several biological pathways, and the most interesting one involves a growth signal called IGF-1. This molecule tells cells to grow, survive, and multiply. Higher circulating levels of IGF-1 have been associated with increased cancer risk because those same growth signals can fuel tumor development.
Exercise changes how your body handles IGF-1 in a surprisingly direct way. During physical activity, working muscles become the primary consumer of IGF-1 from the bloodstream, even surpassing the liver. Muscle cells increase the number of receptors that pull IGF-1 out of circulation, effectively redirecting this growth signal away from other tissues, including the prostate. Men who start with elevated IGF-1 levels see the greatest reductions from exercise, meaning those at highest biological risk may benefit the most.
This isn’t just a theoretical mechanism. Observational studies consistently show that men who exercise vigorously have lower rates of advanced prostate cancer. The effect is strongest with sustained, moderate-to-vigorous activity: think brisk walking, running, cycling, or swimming for at least 150 minutes per week.
Diet: What Helps and What Doesn’t
Cruciferous vegetables like broccoli, cauliflower, kale, and Brussels sprouts contain sulfur-based compounds called glucosinolates. When you chew and digest these vegetables, your body breaks glucosinolates down into active molecules that protect cells from DNA damage, neutralize cancer-causing substances, reduce inflammation, and even trigger damaged cells to self-destruct. In lab studies, these compounds also block tumors from forming new blood vessels and from spreading to other tissues.
The real-world evidence for prostate cancer specifically is mixed. Large cohort studies following men in the U.S., Netherlands, and Europe found little or no clear link between cruciferous vegetable intake and prostate cancer risk. Some smaller studies, however, did find that men eating the most cruciferous vegetables had lower risk. The biological mechanisms are plausible and well-documented; the population-level effect just hasn’t been proven definitively. Eating more of these vegetables is still a reasonable choice given their broad health benefits.
Tomatoes and lycopene (the pigment that makes tomatoes red) have received similar attention. Some studies suggest a modest protective effect, particularly from cooked tomatoes, but the evidence remains inconsistent across large trials.
Supplements That Failed
If you’ve seen ads for selenium or vitamin E supplements marketed for prostate health, ignore them. The SELECT trial, one of the largest cancer prevention trials ever conducted, tested both supplements in over 35,000 men and found that neither selenium nor vitamin E, taken alone or together, prevented prostate cancer. Vitamin E supplements actually increased prostate cancer risk by about 17%. Men who already had high selenium levels and then took additional selenium supplements nearly doubled their chance of developing high-grade prostate cancer. There is no clinical trial evidence supporting any supplement for prostate cancer prevention.
Medications That Reduce Risk
A class of drugs originally designed to treat enlarged prostates has shown a genuine ability to reduce prostate cancer diagnoses. These medications work by blocking the conversion of testosterone into a more potent form that drives prostate cell growth. Clinical trials showed they significantly reduced low-grade prostate cancers.
The catch: early data suggested these drugs might increase the detection of high-grade, more aggressive cancers by about 20%. That finding created enough concern that the FDA added a warning label, and the drugs were never approved specifically for cancer prevention. Longer-term follow-up has not shown increased mortality among men who took these medications, suggesting the apparent rise in aggressive cancers may have been a detection artifact rather than a true increase. Still, these drugs remain off-label for prevention, and most doctors reserve the conversation for men already taking them for urinary symptoms.
Screening Is Not Prevention, but It Matters
Screening with a PSA blood test doesn’t prevent prostate cancer, but it can catch it early when treatment is most effective. Current guidelines recommend that men aged 55 to 69 have an individual conversation with their doctor about whether screening makes sense for them, weighing the benefits of early detection against the risks of overdiagnosis and unnecessary treatment. For men 70 and older, routine PSA screening is generally not recommended because the harms tend to outweigh the benefits at that age.
Men at higher genetic risk, including those with BRCA2 mutations or a strong family history, often begin screening earlier, sometimes in their 40s. If you know you carry a relevant mutation, earlier and more frequent screening is one of the most practical steps available to you.
What a Realistic Prevention Plan Looks Like
You can’t eliminate your prostate cancer risk entirely, but the controllable factors add up. Maintaining a healthy weight keeps your five-year mortality risk roughly half that of overweight men if cancer does develop. Regular vigorous exercise redirects growth signals away from the prostate and lowers circulating levels of the hormones that feed tumor growth. A diet rich in vegetables and low in processed food supports these same pathways, even if no single food has been proven to prevent prostate cancer on its own.
What doesn’t work: megadose supplements, unproven herbal remedies, and the assumption that a healthy lifestyle guarantees safety. Prostate cancer has a strong genetic component, and plenty of fit, health-conscious men develop it. The goal isn’t perfection. It’s shifting the odds in your favor while staying aware of your personal risk profile so you and your doctor can make informed decisions about screening and monitoring.